Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. EHAB
EHAB logo

EHAB Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Enhabit Inc (EHAB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
13.620
1 Day change
52 Week Range
13.680
Analysis Updated At
2026/03/20
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Enhabit Inc (EHAB) is not a strong buy at the moment for a beginner, long-term investor. The stock is trading near its acquisition price of $13.80, limiting upside potential. Additionally, the company's financial performance shows declining net income and EPS, which raises concerns about long-term growth. While there are no significant negative catalysts, the lack of strong positive signals and limited price movement make this stock a hold rather than a buy.

Technical Analysis

The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), but the MACD is below zero and negatively expanding, indicating bearish momentum. RSI is neutral at 72.644. The stock is trading near its pivot level of 13.627, with minimal price movement expected.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
1
Buy
10

Positive Catalysts

  • The company has been acquired by Kinderhook Industries in an all-cash transaction valued at $13.80 per share, providing price stability. Analysts have highlighted improving labor trends, a stable regulatory environment, and operational initiatives as potential tailwinds.

Neutral/Negative Catalysts

  • The company's financials show declining net income (-15.87% YoY) and EPS (-17.39% YoY). The MACD indicates bearish momentum, and there is no significant trading activity or news to drive the stock higher. Analysts have downgraded the stock to Hold due to limited upside potential.

Financial Performance

In Q4 2025, revenue increased by 4.73% YoY to $270.4M, but net income dropped by 15.87% YoY to -$38.7M. EPS also declined by 17.39% YoY to -0.76. Gross margin improved slightly to 46.86%, up 3.24% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is mixed. Jefferies downgraded the stock to Hold with a price target of $13.80, citing the acquisition. Oppenheimer upgraded it to Outperform with a $14 target, citing operational improvements and reimbursement tailwinds. Truist initiated coverage with a Hold rating and a $10.50 price target, citing balanced risk/reward.

Wall Street analysts forecast EHAB stock price to fall
5 Analyst Rating
Wall Street analysts forecast EHAB stock price to fall
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 13.620
sliders
Low
10.5
Averages
12.2
High
14
Current: 13.620
sliders
Low
10.5
Averages
12.2
High
14
Jefferies
Buy
to
Hold
downgrade
AI Analysis
2026-02-23
Reason
Jefferies
Price Target
AI Analysis
2026-02-23
downgrade
Buy
to
Hold
Reason
Jefferies downgraded Enhabit to Hold from Buy with a price target of $13.80, up from $12.50, following the company's agreement to be acquired by Kinderhook Industries in an all-cash transaction valued at $13.80 per share.
Oppenheimer
Perform
to
Outperform
upgrade
$14
2026-01-22
Reason
Oppenheimer
Price Target
$14
2026-01-22
upgrade
Perform
to
Outperform
Reason
Oppenheimer upgraded Enhabit to Outperform from Perform with a $14 price target. The firm believes the post-acute care group is benefiting from "major tailwinds," including strong demand, a more stable regulatory environment, and improving labor trends. Enhabit is positioned to benefit from an improved reimbursement outlook, the analyst tells investors in a research note. In addition, Oppenheimer says the company's operational initiatives should drive the business going forward.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for EHAB
Unlock Now

People Also Watch